Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209913 |
| APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209916 |
| APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2023-11-10 | 2024-01-19 | 209919 |
| APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2022-12-05 | 2023-04-06 | 177123 |
| APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2019-09-25 | 2019-10-22 | 94728 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2019-12-05 | 2019-12-16 | 100255 |
| APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2020-02-05 | 2020-03-06 | 105292 |
| APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-02-13 | 2020-04-07 | 105991 |
| APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-02-26 | 2020-04-07 | 107196 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2020-05-08 | 2020-07-13 | 114282 |
| APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-06-03 | 2020-07-13 | 116377 |
| APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-06-03 | 2020-07-13 | 116382 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2023-12-22 | 2024-02-16 | 214226 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2024-03-01 | 2024-03-15 | 221099 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2024-03-08 | 2024-03-15 | 221708 |
| APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2021-11-08 | 2022-01-24 | 148987 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2018-08-09 | 2018-09-08 | 57769 |
| APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2018-09-04 | 2018-09-21 | 59809 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2018-10-25 | 2018-11-26 | 65588 |
| APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2018-12-05 | 2019-01-18 | 68709 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-FLUVOXAMINE TABLETS | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
| APO-FLUVOXAMINE TABLETS | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |